North South Ventures

North South Ventures is a San Francisco-based venture capital firm specializing in early-stage medical companies. The fund operates with a distinct cross-border investment thesis, seeking to bridge opportunities between North America and other global markets. Their investment focus is broad within the healthcare sector, encompassing Medtech, Digital Health, Healthcare IT, Biotech, Diagnostics, and Life Sciences. This strategic approach allows them to identify innovative solutions with global scalability potential, often leveraging diverse talent pools and market needs.

The firm primarily targets companies in their early stages of development, specifically Seed, Pre-Series A, and Series A rounds. This commitment to early-stage funding underscores their role in nurturing nascent ventures from inception through critical growth phases. North South Ventures not only provides capital but also aims to offer strategic guidance and access to their extensive network, which is particularly valuable for companies navigating international expansion or complex regulatory landscapes.

In terms of investment size, North South Ventures typically deploys initial checks ranging from $250,000 to $1,000,000. This range positions them as a significant early-stage investor capable of providing substantial seed capital or contributing to larger Series A rounds. They also maintain reserves for follow-on investments, indicating a long-term commitment to their portfolio companies as they achieve milestones and require additional funding for scaling. Their disciplined approach to capital deployment, combined with their specialized sector focus, makes them a targeted partner for medical startups with global ambitions.